tiprankstipranks
Trending News
More News >
Adaptimmune Therapeutics Plc. (DE:473A)
:473A

Adaptimmune Therapeutics (473A) Revenue

Compare
0 Followers

Adaptimmune Therapeutics Revenue

Adaptimmune Therapeutics had a revenue of 3.22M in the quarter ending Dec 31, 2024, with -92.12%. This bring the company's revenue in the last twelve months to 178.03M, Decreased 1.71%. In the fiscal year ending Dec 31, 2024, Adaptimmune Therapeutics had annual revenue of 178.03M with 195.34% growth.
Revenue (ttm)
178.03M
Revenue Growth
P/S Ratio
0.36
Revenue/Employee
€351,842
Employees
506
Market Cap
€64.64M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
178.03M117.75M+195.34%
Dec 31, 2023
60.28M33.13M+122.05%
Dec 31, 2022
27.15M21.00M+341.50%
Dec 31, 2021
6.15M2.19M+55.36%
Dec 31, 2020
3.96M2.84M+252.76%
Dec 31, 2019
1.12M-58.38M-98.11%
Dec 31, 2018
59.51M21.67M+57.28%
Dec 31, 2017
37.83M23.64M+166.47%
Dec 31, 2016
14.20M3.48M+32.43%
Jun 30, 2015
10.72M10.12M+1,673.22%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis